These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36890428)

  • 1. The risk of thromboembolism and use of combined oral contraceptives: a comment.
    Birkhäuser M; Böttcher B; Germeyer A; Hadji P; Imthurn B; Mueck AO; Neulen J; Stute P; Thaler CJ; Wiegratz I; Wildt L
    BJOG; 2023 Jun; 130(7):844-845. PubMed ID: 36890428
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on 'Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism'.
    Terplan M; Zuckerman D
    J Fam Plann Reprod Health Care; 2013 Oct; 39(4):304. PubMed ID: 24062505
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on 'Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism': author's response.
    Bitzer J
    J Fam Plann Reprod Health Care; 2013 Oct; 39(4):304-5. PubMed ID: 24062506
    [No Abstract]   [Full Text] [Related]  

  • 4. [Peroral hormonal contraception and risk of venous thromboembolism].
    Ludka O; Spinar J; Musil V; Pozdísek Z
    Vnitr Lek; 2010 May; 56(5):370-5. PubMed ID: 20578585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical profile and recurrence rate in women with venous thromboembolism during combined hormonal contraceptive use: a prospective cohort study.
    van Vlijmen EF; Mäkelburg AB; Knol HM; Tichelaar VI; Kluin-Nelemans HC; Veeger NJ; Meijer K
    Br J Haematol; 2016 Feb; 172(4):636-8. PubMed ID: 26105591
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diffuse symptoms in young women may indicate venous thromboembolism. Important to ask about the use of combined hormonal contraception].
    Milsom I; von Sydow H; Thörn AB; Björkelund C; Odlind V
    Lakartidningen; 2012 Sep 19-26; 109(38):1680-2. PubMed ID: 23094400
    [No Abstract]   [Full Text] [Related]  

  • 7. Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.
    Bitzer J; Amy JJ; Beerthuizen R; Birkhäuser M; Bombas T; Creinin M; Darney PD; Vicente LF; Gemzell-Danielsson K; Imthurn B; Jensen JT; Kaunitz AM; Kubba A; Lech MM; Mansour D; Merki G; Rabe T; Sedlecki K; Serfaty D; Seydoux J; Shulman LP; Sitruk-Ware R; Skouby SO; Szarewski A; Trussell J; Westhoff C
    J Fam Plann Reprod Health Care; 2013 Jul; 39(3):156-9. PubMed ID: 23585363
    [No Abstract]   [Full Text] [Related]  

  • 8. Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism.
    Bitzer J; Amy JJ; Beerthuizen R; Birkhäuser M; Bombas T; Creinin M; Darney PD; Vicente LF; Gemzell-Danielsson K; Imthurn B; Jensen JT; Kaunitz AM; Kubba A; Lech MM; Mansour D; Merki G; Rabe T; Sedlecki K; Serfaty D; Seydoux J; Shulman LP; Sitruk-Ware R; Skouby SO; Szarewski A; Trussell J; Westhoff C
    Eur J Contracept Reprod Health Care; 2013 Jun; 18(3):143-7. PubMed ID: 23578274
    [No Abstract]   [Full Text] [Related]  

  • 9. [Venous thromboembolism and oral contraception].
    Veljković M; Popovć J
    Med Pregl; 2010; 63(5-6):376-9. PubMed ID: 21186550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined hormonal contraception and the risk of venous thromboembolism: a guideline.
    ;
    Fertil Steril; 2017 Jan; 107(1):43-51. PubMed ID: 27793376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Query about Faculty updated UKMEC.
    Lee DJ
    J Fam Plann Reprod Health Care; 2010 Jul; 36(3):181; author reply 181. PubMed ID: 20659387
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective.
    Raymond EG; Burke AE; Espey E
    Obstet Gynecol; 2012 May; 119(5):1039-44. PubMed ID: 22525916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism in women taking hormonal contraceptives.
    Blanco-Molina A; Monreal M
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):211-5. PubMed ID: 20136607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the use of hormonal contraception in Estonia 2005-2019 and the risk of arterial and venous thromboembolism: a population-based study.
    Kurvits K; Laius O; Uusküla M; Laanpere M
    Eur J Contracept Reprod Health Care; 2021 Oct; 26(5):413-420. PubMed ID: 34160334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of hormonal contraceptives-related venous thromboembolism.
    Hugon-Rodin J; Gompel A; Plu-Bureau G
    Eur J Endocrinol; 2014 Dec; 171(6):R221-30. PubMed ID: 25012200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal contraception and risk of venous thromboembolism: national follow-up study.
    Lidegaard Ø; Løkkegaard E; Svendsen AL; Agger C
    BMJ; 2009 Aug; 339():b2890. PubMed ID: 19679613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism associated with estrogen-containing contraceptives versus any hormonal risk factor: a comparison of recurrence rates.
    Wiegers HMG; Knijp J; van Es N; Coppens M; Klok FA; Middeldorp S; Moll S
    J Thromb Haemost; 2023 Jan; 21(1):175-178. PubMed ID: 36695380
    [No Abstract]   [Full Text] [Related]  

  • 18. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN; Slawson JG
    J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
    [No Abstract]   [Full Text] [Related]  

  • 19. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives.
    Shulman LP
    Am J Obstet Gynecol; 2011 Oct; 205(4 Suppl):S9-13. PubMed ID: 21961825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives and venous thromboembolism.
    Dunn N
    BMJ; 2009 Aug; 339():b3164. PubMed ID: 19679617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.